Selatogrel Clinical Trials (2026): 6 Studies for Acute Myocardial Infarction & Healthy Subjects
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
6 Selatogrel clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 4 indications (including Acute Myocardial Infarction & Healthy Subjects) and 25,474 total planned enrollment. 1 Phase 3 Selatogrel trial and 2 Phase 2 are listed. 1 Selatogrel clinical trial is actively recruiting. Most recent activity: NCT04957719 (Dec 2026).
Selatogrel clinical trials at a glance: phase × recruitment status
| Phase | enrolling by invitation | completed | Total |
|---|---|---|---|
| P1 | 3 | 3 | |
| P2 | 2 | 2 | |
| P3 | 1 | 1 |
Recruiting Selatogrel clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT04957719 | SOS-AMISelatogrel Outcome Study in Suspected Acute Myocardial Infarction | P3 | Acute Myocardial Infarction | 25,000 | Aug 2021 |
Selatogrel clinical trials by indication
Acute Myocardial Infarction (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04957719 | SOS-AMI | P3 | enrolling by invitation | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction |
| NCT03487445 | — | P2 | completed | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack |
Healthy Subjects (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04557280 | ACT-246475 | P1 | completed | A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects |
| NCT04406896 | — | P1 | completed | The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics |
Healthy Volunteers (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07133191 | — | P1 | completed | A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants |
Stable Coronary Artery Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT03384966 | — | P2 | completed | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease |
Selatogrel pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| SOS-AMI | NCT04957719 | P3 | enrolling by invitation | Acute Myocardial Infarction | 25,000 | PMID 30153967 |
All Selatogrel trials (6)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04957719 | SOS-AMI | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | P3 | enrolling by invitation | 25,000 | Viatris Innovation GmbH | Aug 2021 |
| NCT07133191 | A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants | P1 | completed | 32 | Viatris Innovation GmbH | Oct 2025 | |
| NCT04557280 | ACT-246475 | A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects | P1 | completed | 24 | Viatris Innovation GmbH | Nov 2020 |
| NCT04406896 | The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics | P1 | completed | 24 | Viatris Innovation GmbH | Jul 2020 | |
| NCT03487445 | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack | P2 | completed | 48 | Viatris Innovation GmbH | Jul 2018 | |
| NCT03384966 | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease | P2 | completed | 346 | Viatris Innovation GmbH | Jan 2018 |
Selatogrel clinical trials: frequently asked questions
- How many Selatogrel clinical trials are there?
- 6 Selatogrel clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 5 are marked completed.
- Are Selatogrel clinical trials recruiting in 2026?
- Yes — 1 Selatogrel trial is actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
- What conditions is Selatogrel being studied for?
- Selatogrel is being studied for Acute Myocardial Infarction, Healthy Subjects, Healthy Volunteers, Hepatic Impairment, Stable Coronary Artery Disease. The trials are grouped by indication on this page.
- What phase is Selatogrel in?
- Selatogrel clinical trials span 1 Phase 3, 2 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Selatogrel clinical trials?
- The lead sponsor across the most Selatogrel trials is Viatris Innovation GmbH. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Selatogrelas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: